DEUTSCHE BANK AG\ - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$741,656
+2.3%
36,196
-0.8%
0.00%
Q2 2023$724,817
-22.4%
36,478
-33.1%
0.00%
-100.0%
Q1 2023$933,945
+10.2%
54,521
+25.9%
0.00%
Q4 2022$847,655
+16.4%
43,314
-5.1%
0.00%
Q3 2022$728,000
+73.3%
45,639
+49.4%
0.00%
Q2 2022$420,000
-36.7%
30,546
-27.0%
0.00%
Q1 2022$664,000
-11.1%
41,872
+22.5%
0.00%
Q4 2021$747,000
-17.6%
34,188
+12.6%
0.00%
Q3 2021$907,000
-35.3%
30,350
-4.1%
0.00%
-100.0%
Q2 2021$1,401,000
-58.1%
31,641
-58.1%
0.00%
-50.0%
Q1 2021$3,347,000
+107.1%
75,433
+156.1%
0.00%
+100.0%
Q4 2020$1,616,000
-74.5%
29,458
-89.4%
0.00%
-75.0%
Q3 2020$6,339,000
+837.7%
277,296
+757.1%
0.00%
+300.0%
Q2 2020$676,000
-90.8%
32,354
-93.8%
0.00%
-85.7%
Q1 2020$7,312,000
+21.5%
524,184
+98.1%
0.01%
+75.0%
Q4 2019$6,020,000
+3441.2%
264,547
+1690.1%
0.00%
Q3 2019$170,000
-56.5%
14,778
-43.5%
0.00%
Q2 2019$391,000
-40.4%
26,144
-30.2%
0.00%
Q1 2019$656,000
-24.9%
37,481
-36.5%
0.00%
-100.0%
Q4 2018$874,000
-85.4%
59,050
-75.8%
0.00%
-50.0%
Q3 2018$5,998,000
-49.3%
243,699
-59.6%
0.00%
-33.3%
Q2 2018$11,826,000
+15460.5%
602,534
+14556.6%
0.00%
Q1 2018$76,0004,1110.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders